SGX:H02Pharmaceuticals
How Investors Are Reacting To Haw Par (SGX:H02) Earnings And EPS Declines In First Half 2026
Haw Par Corporation Limited reported past half-year results for the period ended June 30, 2026, with sales of S$115.93 million and net income of S$107.87 million, both lower than a year earlier.
The drop in basic earnings per share from S$0.651 to S$0.487 highlights weaker profitability from continuing operations over the half-year period.
We’ll now examine how this earnings decline, particularly the reduced basic earnings per share, shapes Haw Par’s investment narrative for investors.
The...